Smoking Cessation: Clinical Trials

146 trials for Smoking Cessation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

114 completed, 10 recruiting, 7 terminated, 5 unknown. 146 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 4146Completed 114, Recruiting 10, Terminated 7, Unknown 5, Withdrawn 5, Active not recruiting 3, Enrolling by invitation 1, Not yet recruiting 1

Follow Smoking Cessation: new trials by email Literature Review of Smoking Cessation trials Research Report on Smoking Cessation

Trials (filtered) newest first · largest first

All 146 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Varenicline for Smoking Cessation in Pancreatitis
Varenicline (VAR) - Pancreatitis, Chronic Pancreatitis
Phase 4Not yet recruitingMayo Clinic452026-11-132026-10-19
My Path to Quit Tobacco
Nicotine patch, Quitline Counseling Phone Calls, Counseling Sessions - Smoking Cessation
Phase 4RecruitingUniversity of Wisconsin, Madison15502026-07-062026-11-10
Varenicline and Accelerated Transcranial Magnetic Stimulation (TMS) for Quitting Nicotine Use (Pilot Study)
Varenicline, Transcranial Magnetic Stimulation, Transcranial Magnetic Stimulation Sham - Nicotine Dependence, Transcranial Magnetic Stimulation
Phase 4RecruitingMassachusetts General Hospital302026-07-022026-09-15
The Options 2 Study
Nicotine Pouches, Mini Nicotine lozenges - Smoker, Smoking Cessation
Phase 4RecruitingUniversity of Wisconsin, Madison3002025-05-212026-06-22
tDCS Plus Varenicline for Smoking Cessation
Active Transcranial Direct Current Stimulation (tDCS), Varenicline 1mg BID, Sham Transcranial Direct Current Stimulation (tDCS) - Nicotine Dependence, Tobacco Smoking
Phase 4RecruitingCentre for Addiction and Mental Health1602025-03-102025-08-12
12-Month Efficacy of Exercise and Cytisinicline for Tobacco Abstinence
Cytisinicline and exercise, Cytisinicline - Smoking Cessation
Phase 4UnknownMaimónides Biomedical Research Institute of Córdoba1502025-01-012024-09-04
Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care
Motivational Interviewing (MI) Counseling, Peer Mentoring, Skills-based Text Messaging - Human Immunodeficiency Virus (HIV), Smoking Cessation
Phase 4RecruitingNew York University5002024-10-182026-11-12
The Avenues Study: Dual Use Cessation
Varenicline, Nicotine patch, Dual Focused Cessation Counseling - Smoking Cessation, Electronic Cigarette Use
Phase 4RecruitingUniversity of Wisconsin, Madison5002024-09-242026-10-07
Transcranial Magnetic Stimulation for Nicotine Dependence: An Effectiveness-Implementation Trial
Brainsway H4 deep Repetitive Transcranial Magnetic Stimulation (rTMS) coil, Nicotine replacement - Tobacco Use Disorder, Psychiatric Disorder
Phase 4RecruitingCentre for Addiction and Mental Health402024-09-012025-12-11
Project HOPES: Healthy Options for Pain and Ending Smoking. A Program for Cancer Survivors.
Smoking cessation and pain management intervention, Varenicline - Smoking Cessation, Pain
Phase 4CompletedDuke University212024-07-152026-08-25
Smoking Cessation Program in the Construction Sector
Nicorette, Tobacco Quit-line, Brief Behavioral Counseling - Smoking Cessation, Tobacco Use Cessation
Phase 4Active not recruitingUniversity of Miami6082024-04-102026-08-21
Implementation of Transcranial Magnetic Stimulation for Smoking Cessation
Brainsway H4 deep rTMS coil and Brainsway stimulator system - Smoking
Phase 4RecruitingCentre for Addiction and Mental Health402024-03-302026-03-27
Treating Caregivers Who Smoke at AFCH
Nicotine Replacement Product - Smoking, Smoking Cessation
Phase 4CompletedUniversity of Wisconsin, Madison232024-03-052026-04-16
Tobacco Treatment Comparison for Cancer Care
Transdermal Nicotine Patch, Standard Telephone Counseling, Varenicline - Smoking Cessation, Cancer
Phase 4CompletedUniversity of Wisconsin, Madison522024-03-012025-10-27
Botswana Smoking and Abstinence Reinforcement Trial
Screening, Brief Intervention and Referral to Treatment (SBIRT) intervention consisting of the 5As, (Ask, Advise, Assess, Assist, Arrange), Varenicline - Smoking Cessation, Hiv
Phase 4Enrolling by invitationUniversity of Maryland, Baltimore7502023-07-252026-01-09
BREATHE 2 Clinic Stop-Smoking Treatment Outreach Study
Text message smoking treatment, Nicotine replacement therapy sampling, Wisconsin Tobacco QuitLine Referral - Quitting Smoking, Smoking Cessation
Phase 4CompletedUniversity of Wisconsin, Madison123762023-07-242026-06-26
TOBacco STOP in Chronic Obstructive Pulmonary Disease-Trial - Study Protocol
High-intensity smoking cessation intervention, Low-intensity smoking cessation intervention - Chronic Obstructive Pulmonary Disease, Smoking Cessation
Phase 4WithdrawnPradeesh Sivapalan2023-07-012023-02-23
Cytisine for Smoking Cessation
Cytisine, Placebo - Tobacco Use Disorder, Alcohol Use Disorder
Phase 4CompletedCentre for Addiction and Mental Health202023-02-082026-02-27
Smoking Cessation and Menstrual Cycle Phase
Timing of nicotine replacement therapy start date, Nicotine Replacement Therapy Agent - Nicotine Dependence, Tobacco Smoking
Phase 4RecruitingCentre for Addiction and Mental Health12002022-11-302026-03-19
Modifying Progesterone and Estradiol Levels to Prevent Postpartum Cigarette Smoking Relapse and Reduce Secondhand Smoke Exposure in Infants and Children
Progesterone 200 MG Oral Capsule - Smoking, Smoking Cessation
Phase 4RecruitingUniversity of Minnesota1712022-04-142026-07-13

Showing 20 of 146. Sign in to see all of them.

Narrower conditions

Tobacco Use Disorder (44)  ·  Smoking (39)  ·  Schizophrenia (11)  ·  Cigarette Smoking (8)  ·  Psychotic Disorders (7)  ·  Tobacco Smoking (6)  ·  Mental Disorders (5)  ·  Substance-Related Disorders (5)  ·  Tobacco Use Cessation (5)  ·  Vaping (5)  ·  Acquired Immunodeficiency Syndrome (4)  ·  Pulmonary Disease, Chronic Obstructive (4)  ·  Recurrence (4)  ·  Alcoholism (3)

Broader conditions

Behavior (146)  ·  Health Behavior (145)  ·  Mental Disorders (54)  ·  Chemically-Induced Disorders (48)  ·  Substance-Related Disorders (43)  ·  Smoking (15)  ·  Pathological Conditions, Signs and Symptoms (14)  ·  Pathologic Processes (11)  ·  Schizophrenia Spectrum and Other Psychotic Disorders (11)  ·  Disease Attributes (10)  ·  Tobacco Use (10)  ·  Immune System Diseases (7)  ·  Infections (7)  ·  Tobacco Smoking (7)  ·  Blood-Borne Infections (5)

Interventions

Varenicline (54)  ·  Tobacco Use Cessation Devices (39)  ·  Bupropion (22)  ·  Nicotine (17)  ·  Nicotine Replacement Therapy (17)  ·  Nicotine Chewing Gum (14)  ·  Counseling (8)  ·  Motivational Interviewing (7)  ·  Behavior Therapy (5)  ·  Crisis Intervention (4)  ·  Transdermal Patch (4)  ·  BID protein, human (3)  ·  Chewing Gum (3)  ·  cytisine (3)  ·  Nebulizers and Vaporizers (2)

Sponsors

University of Wisconsin, Madison (18)  ·  Pfizer (11)  ·  Centre for Addiction and Mental Health (9)  ·  Massachusetts General Hospital (7)  ·  Duke University (5)  ·  Ottawa Heart Institute Research Corporation (5)  ·  University of Miami (5)  ·  University of Alabama at Birmingham (3)  ·  University of California, San Francisco (3)  ·  Yale University (3)  ·  National Institute on Drug Abuse (NIDA) (2)  ·  North Suffolk Mental Health Association (2)  ·  Shaare Zedek Medical Center (2)  ·  Stanford University (2)  ·  Swedish Match AB (2)

Countries

United States (99)  ·  Canada (22)  ·  Germany (8)  ·  Brazil (5)  ·  France (5)  ·  Mexico (5)  ·  Spain (5)  ·  Australia (4)  ·  Russia (4)  ·  United Kingdom (4)  ·  Argentina (3)  ·  Czechia (3)  ·  Denmark (3)  ·  Finland (3)  ·  South Africa (3)

Top investigators

Andrew Pipe, MD (4)  ·  A Eden Evins, MD, MPH (3)  ·  Megan Piper, PhD (3)  ·  Taghrid Asfar, MD (3)  ·  Anne M. Joseph, MD MPH (2)  ·  Danielle E McCarthy, PhD (2)  ·  Jessica Cook, PhD (2)  ·  Laurie A Zawertailo, PhD (2)  ·  Laurie Zawertailo, PhD (2)  ·  Megan E Piper, PhD (2)  ·  Michael C Fiore, MD, MPH, MBA (2)  ·  Nancy A Rigotti, MD (2)  ·  Peter Selby, MD, MHSc (2)

Results publications

PMID 37142273, PMID 37230961, PMID 37335995, PMID 34611902, PMID 39868569, PMID 26336372, PMID 10191796, PMID 10417762, PMID 10493090, PMID 10510989, PMID 10581887, PMID 10740940, PMID 10748642, PMID 10791509, PMID 10812284, PMID 10885042, PMID 10901493, PMID 11176814, PMID 11236847, PMID 11260806, PMID 11282701, PMID 11377644, PMID 11516593, PMID 12010856, PMID 1202204, PMID 12028847, PMID 12047734, PMID 12095672, PMID 12438835, PMID 12439223, PMID 12492263, PMID 12814497, PMID 1453243, PMID 14982685, PMID 15010446, PMID 1511534, PMID 15138759, PMID 15203809, PMID 15370156, PMID 15370939, PMID 15539711, PMID 15586837, PMID 15631608, PMID 15820329, PMID 15955146, PMID 16036283, PMID 16123753, PMID 1613610, PMID 16157462, PMID 16203030

NIH funding

P01CA180945 (4), P50CA143188 (3), 1RC1CA144382-01 (1), K01DA043413 (1), K02DA034767 (1), K23DA038717 (1), K23RR018471 (1), R01CA165080 (1), R01CA184211 (1), R01CA218156 (1), R01CA290895 (1), R01CA291761 (1), R01DA004174 (1), R01DA017441 (1), R01DA021245 (1)